A descriptive research: Exclusion from submitted clinical data package in the review process of new drug approval due to GCP violation in Japan

MLA

Ryuta Asada, et al. “A Descriptive Research: Exclusion from Submitted Clinical Data Package in the Review Process of New Drug Approval Due to GCP Violation in Japan.” Contemporary Clinical Trials Communications, vol. 15, no., Sept. 2019. EBSCOhost, https://doi.org/10.1016/j.conctc.2019.100416.

APA

Ryuta Asada, Kenichi Yoshimura, Kayo Hattori, Yujiro Nonaka, Hiroi Kasai, & Shinobu Shimizu. (2019). A descriptive research: Exclusion from submitted clinical data package in the review process of new drug approval due to GCP violation in Japan. Contemporary Clinical Trials Communications, 15. https://doi.org/10.1016/j.conctc.2019.100416

Chicago

Ryuta Asada, Kenichi Yoshimura, Kayo Hattori, Yujiro Nonaka, Hiroi Kasai, and Shinobu Shimizu. 2019. “A Descriptive Research: Exclusion from Submitted Clinical Data Package in the Review Process of New Drug Approval Due to GCP Violation in Japan.” Contemporary Clinical Trials Communications 15. doi:10.1016/j.conctc.2019.100416.